2021

1. Salvage brachytherapy for locally recurrent prostate cancer after single-fraction 19 Gy high-dose-rate brachytherapy: Toxicity, prostatespecific antigen kinetics, and cancer control

   Journal of Contemporary Brachytherapy, Vol. 13, Núm. 1, pp. 12-17